Try our Advanced Search for more refined results
October 04, 2018
Reinmann v. TG Therapeutics, Inc. et al
Case Number:
1:18-cv-09104
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
October 04, 2018
Biopharma Co. Sued After Leukemia Treatment Trial Fails
A TG Therapeutics Inc. stockholder filed a proposed class action in New York federal court on Thursday accusing the biopharmaceutical company of making optimistic statements about the clinical trial performance of two drugs used to treat leukemia despite knowing that the drug therapy had failed.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login